Alpha Tau Medical Ltd. announced that Stephen M. Hahn, M.D., former commissioner of the U.S. Food and Drug Administration (?FDA?), has joined its Scientific Advisory Board. A distinguished expert in the field of radiation oncology and translational/clinical research, and a renowned physician, Dr. Hahn brings a wealth of regulatory and scientific experience to the Company as it advances its Alpha DaRT technology towards FDA clearance. Dr. Hahn is currently CEO-Partner of Flagship Pioneering and CEO of Harbinger Health, where he specializes in innovating in the field of preventive health care and global health strategy.

He previously served as FDA Commissioner from 2019 to 2021, overseeing regulatory affairs, including therapeutics and vaccine development, devices, diagnostics, and clinical trials. Prior to his FDA appointment, Dr. Hahn served as chief medical executive, deputy president, and chief operating officer at the world renowned MD Anderson Cancer Center in Houston, Texas. Prior to his executive leadership roles at MD Anderson, Dr. Hahn was at the helm of radiation oncology at the University of Pennsylvania?s Perelman School of Medicine.